Devaraj E, Perumal E, Subramaniyan R, Mustapha N. Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology. 2022;76:275–285
Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218
CAS PubMed PubMed Central Google Scholar
Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397–411
Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56:1171–1180
Senoo H, Kojima N, Sato M. Vitamin A-storing cells (stellate cells). Vitam Horm. 2007;75:131–159
Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A. 2014;111:E3297-3305
CAS PubMed PubMed Central Google Scholar
Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151–166
Park JS, Ma H, Roh YS. Ubiquitin pathways regulate the pathogenesis of chronic liver disease. Biochem Pharmacol. 2021;193: 114764.
Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159–192
Zhang JL, Du BB, Zhang DH, Li H, Kong LY, Fan GJ, et al. OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. Hepatology. 2022;75:1218–34.
Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, et al. USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma. Nat Commun. 2022;13:2187
CAS PubMed PubMed Central Google Scholar
Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci (Weinh). 2023;10: e2302953
Li X, Yang G, Zhang W, Qin B, Ye Z, Shi H, et al. USP13: multiple functions and target inhibition. Front Cell Dev Biol. 2022;10: 875124
PubMed PubMed Central Google Scholar
Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, et al. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. J Exp Med. 2017;214:245–67.
CAS PubMed PubMed Central Google Scholar
Liu Y, Li Z, Xiao H, Xie B, He J, Song M, et al. Usp13 deficiency impairs autophagy and facilitates age-related lung fibrosis. Am J Respir Cell Mol Biol. 2023;68:49–61
Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–38.
Yuan Y, Li Y, Wu X, Bo J, Zhang L, Zhang J, et al. POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis. Cancer Lett. 2024;582: 216526.
Yuan S, Wang Z, Yao S, Wang Y, Xie Z, Wang J, et al. Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction. Theranostics. 2024;14:5793–5808
CAS PubMed PubMed Central Google Scholar
Ma C, Wang D, Tian Z, Gao W, Zang Y, Qian L, et al. USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation. Oncogene. 2023;42:2249–2262
CAS PubMed PubMed Central Google Scholar
Zhang P, Wang PX, Zhao LP, Zhang X, Ji YX, Zhang XJ, et al. The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat Med. 2018;24:84–94
Luo P, Qin C, Zhu L, Fang C, Zhang Y, Zhang H, et al. Ubiquitin-specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology. 2018;68:1786–803.
Zhou B, Luo Y, Bi H, Zhang N, Ma M, Dong Z, et al. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11. Cell Metab. 2024;36(2228–2244): e2227
Zhao J, Bai J, Peng F, Qiu C, Li Y, Zhong L. USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. Cell Death Dis. 2023;14:40
CAS PubMed PubMed Central Google Scholar
Xu F, Liu C, Zhou D, Zhang L. TGF-beta/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157–167
CAS PubMed PubMed Central Google Scholar
Sinha A, Iyengar PV, Ten Dijke P. E3 Ubiquitin Ligases: Key Regulators of TGFbeta Signaling in Cancer Progression. Int J Mol Sci 2021;22.
Chen N, Balasenthil S, Reuther J, Killary AM. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity. Cancer Res. 2014;74:5683–5689
CAS PubMed PubMed Central Google Scholar
Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, et al. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell. 2001;12:1431–43.
CAS PubMed PubMed Central Google Scholar
Herhaus L, Al-Salihi M, Macartney T, Weidlich S, Sapkota GP. OTUB1 enhances TGFbeta signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun. 2013;4: 2519.
Galant C, Marchandise J, Stoenoiu MS, Ducreux J, De Groof A, Pirenne S, et al. Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor beta. Rheumatology (Oxford). 2019;58:708–718
Xu M, Tan J, Zhu L, Ge C, Dong W, Dai X, et al. The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. Acta Pharm Sin B. 2023;13:1071–1092
Lai Q, Li W, Hu D, Huang Z, Wu M, Feng S, et al. Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles. J Control Release. 2024;376:601–17.
Huang J, Huang H, Wang Y, Xu B, Lin M, Han S, et al. Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation. Biomaterials. 2023;299: 122134
Zhou Z, Feng Y, Jiang M, Yao Z, Wang J, Pan F, et al. Ionizable polymeric micelles (IPMs) for efficient siRNA delivery. Nat Commun. 2025;16:360
Comments (0)